Neuroimmunology News

Dec 17, 2019
Flashing lights may provide vital first test of multiple sclerosis drug success
Measuring changes in the speed of electrical signals along nerves connecting the eyes to the brain may accurately reflect recovery from myelin loss in multiple sclerosis.
Oct 30, 2019
FDA approves diroximel fumarate for relapsing forms of multiple sclerosis
Drug is a novel oral fumarate with a distinct chemical structure that is designed to impact its gastrointestinal tolerability.
Aug 20, 2019
How to improve multiple sclerosis therapy
New drugs haven't brought about any significant improvement in the treatment of progressive multiple sclerosis. For a variety of reasons.
Aug 09, 2019
Adding multiple sclerosis drug to targeted cancer therapy may improve glioblastoma outcomes
By reaching stem cells at the tumor's root, multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice.
Jul 31, 2019
Vaccinations not a risk factor for multiple sclerosis
Big-data analysis shows no correlation between vaccinations and multiple sclerosis.
Jun 28, 2019
FDA approves first treatment for neuromyelitis optica spectrum disorder
Approval changes the landscape of therapy for patients with the disorder.
May 10, 2019
Statins’ potential to treat MS unrelated to lowering cholesterol
Widely prescribed statin can medically help patients with secondary progressive multiple sclerosis.
May 03, 2019
Study shows drug reduces risk of relapse with neuromyelitis optica
New study results confirm the important role of complement in neuromyelitis optica.
May 02, 2019
Out-of-pocket costs for neurologic medications rise sharply over 12 years
Sharpest increase for multiple sclerosis drugs.
Apr 28, 2019
FDA approves first treatment for pediatric patients with lupus
Drug fulfils unmet need for therapies, specifically in pediatric patients with systemic lupus erythematosus.
◀ Previous   Next ▶